v3.25.4
Stockholders Equity (Details Narrative)
12 Months Ended
Sep. 17, 2021
USD ($)
integer
$ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
May 07, 2024
USD ($)
$ / shares
Referral agreement term 5 years      
Common stock, par value | $ / shares   $ 0.001 $ 0.001  
Gross proceeds from sale   $ 1,149,288 $ 0  
Class of warrant or right, term 7 years      
Class of warrant or right, granted in period (in shares) | shares 30,000      
Exercise price of warrant (in usd per share) | $ / shares $ 7.20      
Number of tranches | integer 2      
Warrants outstanding (in shares) $ 149,551      
Warrants outstanding, term 7 years      
Shares vested (in shares) | shares   10,700    
Forfeited (in shares) | shares   19,300    
June 10 2025 [Member]        
Reverse stock split   1-for-10    
Measurement Input, Implied Volatility        
Warrants outstanding, measurement input 100.00%      
Measurement Input, Risk-free Yield        
Warrants outstanding, measurement input 1.17%      
Measurement Input, Share Price        
Warrants outstanding, stock price | $ / shares $ 7.10      
ATM Agreement [Member]        
Common stock, par value | $ / shares       $ 0.001
Aggregate offering price       $ 15,000,000.0
Common stock, shares sold | shares   165,641    
Gross proceeds from sale   $ 1,184,740    
Net proceeds from sale   $ 1,149,288